Intravitreal triamcinolone for intraocular inflammation and associated macular edema

Steven M. Couch, Sophie J. Bakri

Research output: Contribution to journalReview articlepeer-review

47 Scopus citations


Triamcinolone acetonide (TA) is a corticosteroid that has many uses in the treatment of ocular diseases because of its potent anti-inflammatory and anti-permeability actions. Intraocular inflammation broadly referred to as uveitis can result from several causes, including the immune system and after ophthalmic surgery. One of the most common reasons for vision loss with uveitis is macular edema. TA has been used for many years as an intravitreal injection for the treatment of ocular diseases. Several case control studies have been reported showing the efficacy of TA in the treatment of intraocular inflammation and associated macular edema caused by Behcet's disease, Vogt-Koyanagi-Harada syndrome, sympathetic ophthalmia and white dot syndromes. It has also been shown efficacious in cases of pars planitis and idiopathic posterior uveitis. Some authors have reported its use in postoperative cystoid macular edema. Many of the studies on the use of TA in controlling intraocular inflammation and concomitant macular edema showed its effect to be transient in many patients requiring reinjection. Complications can arise from intravitreal injection of TA including elevated intraocular pressure and cataract. Rarely, it can be associated with infectious and non-infectious endophthalmitis. TA may be useful as an adjuvant in the treatment of uveitis and its associated macular edema, especially in patients resistant or intolerant to standard treatment.

Original languageEnglish
Pages (from-to)41-47
Number of pages7
JournalClinical Ophthalmology
Issue number1
StatePublished - Dec 1 2009


  • Behcet's disease
  • Cataract surgery
  • Endophthalmitis
  • Macular edema
  • Sympathetic ophthalmia
  • Triamcinolone acetonide
  • Uveitis
  • Vogt-Koyanagi-Harada syndrome
  • White dot syndromes


Dive into the research topics of 'Intravitreal triamcinolone for intraocular inflammation and associated macular edema'. Together they form a unique fingerprint.

Cite this